These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Substantial non-electrostatic forces are needed to induce allosteric disruption of thrombin's active site through exosite 2. Mehta AY, Desai UR. Biochem Biophys Res Commun; 2014 Sep 26; 452(3):813-6. PubMed ID: 25201728 [Abstract] [Full Text] [Related]
14. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats. Song Q, Wang S, Zhao W. J Ethnopharmacol; 2012 May 07; 141(1):183-6. PubMed ID: 22366682 [Abstract] [Full Text] [Related]
16. Enhanced anticoagulant activity of enoxaparin in patients with ESRD as measured by thrombin generation time. Brophy DF, Martin EJ, Gehr TW, Carr ME. Am J Kidney Dis; 2004 Aug 07; 44(2):270-7. PubMed ID: 15264185 [Abstract] [Full Text] [Related]
17. Synthesis and in Vitro and in Vivo Anticoagulant and Antiplatelet Activities of Amidino- and Non-Amidinobenzamides. Lee SH, Lee W, Bae JS, Ma E. Molecules; 2016 May 21; 21(5):. PubMed ID: 27213328 [Abstract] [Full Text] [Related]
19. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin. Mousa SA, Linhardt R, Francis JL, Amirkhosravi A. Thromb Haemost; 2006 Dec 21; 96(6):816-21. PubMed ID: 17139378 [Abstract] [Full Text] [Related]